This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Champions Oncology (NASDAQ:CSBR)CurrentInstitutional OwnershipPercentage41.30%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$1.88MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.70M Get CSBR Insider Trade Alerts Want to know when executives and insiders are buying or selling Champions Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CSBR Institutional Buying and Selling by Quarter Champions Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.23,129$201K0.0%N/A0.167% 5/21/2025Acadian Asset Management LLC39,511$341K0.0%+28.7%0.286% 5/19/2025Jane Street Group LLC23,020$200K0.0%N/A0.167% 5/16/2025Goldman Sachs Group Inc.23,129$201K0.0%N/A0.167% 5/15/2025OMERS ADMINISTRATION Corp10,700$93K0.0%N/A0.077% 5/13/2025Tocqueville Asset Management L.P.399,882$3.47M0.1%-34.3%2.894% 5/13/2025Informed Momentum Co LLC79,987$694K0.1%N/A0.579% 5/13/2025HighTower Advisors LLC35,158$305K0.0%-10.6%0.254% 2/14/2025Northern Trust Corp53,994$463K0.0%+31.5%0.391% 2/13/2025Renaissance Technologies LLC138,839$1.19M0.0%+15.7%1.005% Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025Geode Capital Management LLC66,511$570K0.0%+2.2%0.481% 2/11/2025Virtu Financial LLC11,051$95K0.0%N/A0.080% 2/10/2025Tocqueville Asset Management L.P.608,915$5.22M0.1%-13.7%4.406% 11/15/2024HighTower Advisors LLC39,308$191K0.0%+14.6%0.289% 4/26/2024Mesirow Financial Investment Management Inc.12,380$61K0.0%N/A0.091% 2/13/2024Aristides Capital LLC11,822$66K0.0%-45.3%0.087% 2/8/2024Essex Investment Management Co. LLC77,200$434K0.1%-26.7%0.568% 11/9/2023Essex Investment Management Co. LLC105,335$654K0.1%-5.4%0.781% 5/15/2023Overbrook Management Corp48,488$195K0.1%-10.0%0.358% 5/10/2023Tocqueville Asset Management L.P.665,428$2.68M0.1%+8.2%4.907% 2/9/2023Tocqueville Asset Management L.P.615,228$2.78M0.1%+80.1%4.537% 11/15/2022Essex Investment Management Co. LLC107,711$808K0.1%-6.4%0.797% 11/14/2022Ergoteles LLC13,937$105K0.0%N/A0.103% 10/31/2022Millrace Asset Group Inc.346,976$2.60M3.3%-2.0%2.566% 7/28/2022Millrace Asset Group Inc.354,041$2.83M2.7%+7.6%2.619% 5/9/2022Essex Investment Management Co. LLC115,075$936K0.1%+8.1%0.851% 2/10/2022Essex Investment Management Co. LLC106,423$890K0.1%+18.9%0.787% 2/3/2022ACT Capital Management LLC62,500$523K0.4%+6.8%0.462% 11/16/2021ACT Capital L.L.C.58,500$597K0.3%+17.0%0.436% 11/15/2021Dimensional Fund Advisors LP119,902$1.22M0.0%-8.2%0.893% 11/15/2021HighTower Advisors LLC26,467$270K0.0%+36.2%0.197% 11/12/2021Renaissance Technologies LLC221,146$2.26M0.0%-3.0%1.648% 11/9/2021Essex Investment Management Co. LLC89,507$914K0.1%-1.8%0.667% 11/9/2021BlackRock Inc.122,398$1.25M0.0%+14.4%0.912% 8/17/2021Millennium Management LLC88,310$908K0.0%N/A0.658% 8/16/2021State Street Corp24,163$248K0.0%-76.2%0.180% 8/13/2021Northern Trust Corp27,719$285K0.0%-68.8%0.207% 8/13/2021Overbrook Management Corp94,940$976K0.2%-1.8%0.708% 8/13/2021Geode Capital Management LLC42,953$441K0.0%-53.7%0.320% 8/13/2021Vanguard Group Inc.327,636$3.37M0.0%-29.5%2.442% A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how8/12/2021Dimensional Fund Advisors LP130,655$1.34M0.0%+1.8%0.974% 8/12/2021JPMorgan Chase & Co.4,379$45K0.0%-78.4%0.033% 8/12/2021Bank of Montreal Can102,934$1.09M0.0%+39.1%0.767% 8/12/2021Ergoteles LLC30,900$318K0.0%N/A0.230% 8/11/2021Millrace Asset Group Inc.280,439$2.88M1.5%+7.8%2.090% 8/11/2021Bank of New York Mellon Corp51,825$533K0.0%-24.1%0.386% 8/11/2021Susquehanna Fundamental Investments LLC28,382$292K0.0%N/A0.212% 7/31/2021Roubaix Capital LLC351,507$3.61M2.3%+25.9%2.621% 5/18/2021California State Teachers Retirement System9,731$110K0.0%-10.6%0.073% 5/17/2021Aristides Capital LLC36,750$415K0.2%-8.1%0.274% 5/14/2021Dimensional Fund Advisors LP128,293$1.45M0.0%-2.4%0.958% 5/13/2021Barclays PLC5,658$64K0.0%+171.8%0.042% 5/13/2021Renaissance Technologies LLC228,433$2.58M0.0%+3.0%1.706% 5/12/2021Northern Trust Corp88,943$1.01M0.0%-17.1%0.664% 5/12/2021JPMorgan Chase & Co.20,287$229K0.0%+7.8%0.152% 5/12/2021UBS Group AG2,553$29K0.0%+165.7%0.019% (Data available from 1/1/2016 forward) CSBR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CSBR shares? During the previous two years, 14 institutional investors and hedge funds held shares of Champions Oncology. The most heavily invested institutionals were Tocqueville Asset Management L.P. ($3.47M), Renaissance Technologies LLC ($1.19M), Informed Momentum Co LLC ($694K), Geode Capital Management LLC ($570K), Northern Trust Corp ($463K), Essex Investment Management Co. LLC ($434K), and Acadian Asset Management LLC ($341K).Learn more on Champions Oncology's institutional investors. What percentage of Champions Oncology's stock is owned by institutional investors? 41.30% of Champions Oncology's stock is owned by institutional investors. Learn more on CSBR's institutional investor holdings. Which institutional investors have been buying Champions Oncology's stock? Of the 11 institutional investors that purchased Champions Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Informed Momentum Co LLC ($79.99K), Goldman Sachs Group Inc. ($46.26K), Jane Street Group LLC ($23.02K), Renaissance Technologies LLC ($18.85K), Northern Trust Corp ($12.92K), Mesirow Financial Investment Management Inc. ($12.38K), and Virtu Financial LLC ($11.05K). How much institutional buying is happening at Champions Oncology? Institutional investors have bought a total of 218,048 shares in the last 24 months. This purchase volume represents approximately $1.88M in transactions. Which of Champions Oncology's major shareholders have been selling company stock? The following institutional investors have sold Champions Oncology stock in the last 24 months: Tocqueville Asset Management L.P. ($305.33K), and HighTower Advisors LLC ($4.15K). How much institutional selling is happening at Champions Oncology? Institutional investors have sold a total of 309,482 shares in the last 24 months. This volume of shares sold represents approximately $2.70M in transactions. Related Companies TRML Institutional Ownership ANNA Institutional Ownership ALT Institutional Ownership SVRA Institutional Ownership AQST Institutional Ownership RIGL Institutional Ownership HRTX Institutional Ownership NKTR Institutional Ownership NATR Institutional Ownership TNXP Institutional Ownership This page (NASDAQ:CSBR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.